AstraZeneca, Accord Settle Seroquel XR Patent Spat
Pharmaceutical giant AstraZeneca PLC announced Wednesday that it had reached a patent settlement over its antipsychotic drug Seroquel XR with Accord Healthcare Ltd. and parent company Intas Pharmaceuticals Ltd., just a...To view the full article, register now.
Already a subscriber? Click here to view full article